Xintela AB (publ) (STO:XINT)
Sweden · Delayed Price · Currency is SEK 0.1670
+0.0095 (6.03%)
Sep 22, 2026, 1:34 PM CET
Xintela AB Market Cap
Xintela AB has a market cap or net worth of 143.83 million as of September 22, 2026. Its market cap has decreased by -53.17% in one year.
Market Cap
143.83M
Enterprise Value
165.00M
Revenue
3.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.17
ChartMarket Cap Chart
Since March 22, 2016, Xintela AB's market cap has increased from 103.68M to 143.83M, an increase of 38.73%. That is a compound annual growth rate of 3.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 143.83M | -27.61% |
| Dec 30, 2025 | 198.68M | 5.85% |
| Dec 30, 2024 | 187.69M | 26.87% |
| Dec 29, 2023 | 147.94M | -1.74% |
| Dec 30, 2022 | 150.56M | -26.24% |
| Dec 30, 2021 | 204.12M | 2.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Elicera Therapeutics AB | 181.19M |
| Abera Bioscience AB | 159.48M |
| Diamyd Medical AB | 159.01M |
| Initiator Pharma | 149.91M |
| Simris Group AB (PUBL) | 139.70M |
| NextCell Pharma AB | 136.25M |
| Active Biotech AB | 115.20M |
| Nanologica AB | 101.92M |